# BENDAMUSTINE HYDROCHLORIDE
> **NDA216078** · New Drug Application · Sponsor: BAXTER HLTHCARE CORP · Approved 2022-12-15
## Drug
- **FDA Application Number:** NDA216078
- **Application type:** New Drug Application
- **Brand name:** BENDAMUSTINE HYDROCHLORIDE
- **Generic name:** BENDAMUSTINE HYDROCHLORIDE
- **Active ingredients:** BENDAMUSTINE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** BAXTER HLTHCARE CORP
- **Manufacturer:** Baxter Healthcare Corporation
- **First approval:** 2022-12-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216078)
---
*AI Analytics · CC0 1.0*